Landmark UK-US pharmaceuticals deal to safeguard medicines access and drive vital investment for UK patients and businesses

Office for Artificial Intelligence UK Published: 2025-12-01 00:00:00

Milestone deal secures UK’s medicines access for patients, with a wide range of groundbreaking new treatments to reach NHS front-line quicker.

No full content stored. Use “Open Source” to read the original.

Open Source →

Recommended reads

OpenAI and Microsoft join UK’s international coalition to safeguard AI development From UK

OpenAI and Microsoft pledge funding to AI Security Institute’s Alignment Project: an international effort on AI systems that are safe, secure and under control.

Office for Artificial Intelligence · UK 2026-02-19

Bold bet on AI to keep UK at forefront of science and research breakthroughs from healthcare, to better public services From UK

First-ever AI Strategy for UK Research and Innovation marks bold plan to make AI deliver for UK’s cutting-edge science and research efforts.

Office for Artificial Intelligence · UK 2026-02-19

Tech firms will have to take down abusive images within 48 hours under new law to protect women and girls From UK

New law requires tech platforms to take down non-consensual intimate images within 48 hours or face fines.

Office for Artificial Intelligence · UK 2026-02-19

Landmark UK-US pharmaceuticals deal to safeguard medicines access and drive vital investment for UK patients and businesses

Landmark UK-US pharmaceuticals deal to safeguard medicines access and drive vital investment for UK patients and businesses